{"created":"2023-06-19T11:23:58.234892+00:00","id":4605,"links":{},"metadata":{"_buckets":{"deposit":"da34f8eb-04a4-4b0e-b546-bc58ba3e1496"},"_deposit":{"created_by":3,"id":"4605","owners":[3],"pid":{"revision_id":0,"type":"depid","value":"4605"},"status":"published"},"_oai":{"id":"oai:asahikawa-med.repo.nii.ac.jp:00004605","sets":["7","7:23"]},"author_link":["14252","14253"],"item_5_biblio_info_21":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2012-12-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"1281","bibliographicPageStart":"1275","bibliographicVolumeNumber":"30","bibliographic_titles":[{"bibliographic_title":"カレントテラピー"}]}]},"item_5_description_33":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"近年,各領域の配合剤が開発され,一般臨床においてその使用頻度は徐々に増えつつある.国内では降圧薬の合剤が5年前から発売されており,降圧作用に相乗作用が期待されること,副作用が相殺され得ること,医療経済上のメリットが大きいことなどから,降圧薬シエアのなかで大きな位置を占めつつある.一方,降圧薬と脂質降下薬,糖尿病薬の合剤も相次いで発売され,生活習慣病関連の配合剤の選択肢が増えている.配合剤の処方においては単剤の併用と同等以上の効果を有し,副作用が軽減されることがメリットとなるが,一方で微量調節しにくいことや,副作用が生じた場合には,どの薬の影響か判定しにくいことなどのデメリットもある.配合剤の使用によりアドヒアランスの向上を介して血圧,血糖,脂質目標達成率が高くなること,より早い目標達成が得られることが期待されるが,安全面を含めて,今後のさらなるデータの蓄積が必要と考えられる","subitem_description_language":"ja","subitem_description_type":"Abstract"}]},"item_5_description_36":{"attribute_name":"注記","attribute_value_mlt":[{"subitem_description":"雑誌掲載版","subitem_description_type":"Other"}]},"item_5_description_37":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"subitem_description":"text","subitem_description_type":"Other"}]},"item_5_description_41":{"attribute_name":"フォーマット","attribute_value_mlt":[{"subitem_description":"application/pdf","subitem_description_type":"Other"}]},"item_5_source_id_22":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0287-8445","subitem_source_identifier_type":"PISSN"}]},"item_5_text_44":{"attribute_name":"ID(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"2013099040"}]},"item_5_text_54":{"attribute_name":"閲覧数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"864"}]},"item_5_text_55":{"attribute_name":"ダウンロード数(XooNIps)","attribute_value_mlt":[{"subitem_text_value":"888"}]},"item_5_text_7":{"attribute_name":"著者 ローマ字","attribute_value_mlt":[{"subitem_text_value":"Hasebe, Naoyuki"},{"subitem_text_language":"en"}]},"item_5_version_type_38":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"佐藤, 伸之","creatorNameLang":"ja"},{"creatorName":"サトウ, ノブユキ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"14252","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"長谷部, 直幸","creatorNameLang":"ja"},{"creatorName":"ハセベ, ナオユキ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"14253","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2021-07-06"}],"displaytype":"detail","filename":"5398.pdf","filesize":[{"value":"10.5 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"5398.pdf","url":"https://asahikawa-med.repo.nii.ac.jp/record/4605/files/5398.pdf"},"version_id":"299d54cb-00ac-4e23-ae0c-c0ac7b5f0e43"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"【配合剤の現状と展望】 配合剤でより早い血圧、血糖、脂質目標達成は可能か? アドヒアランスの問題も含めて","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"【配合剤の現状と展望】 配合剤でより早い血圧、血糖、脂質目標達成は可能か? アドヒアランスの問題も含めて","subitem_title_language":"ja"}]},"item_type_id":"5","owner":"3","path":["6","7","23"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2013-08-28"},"publish_date":"2013-08-28","publish_status":"0","recid":"4605","relation_version_is_last":true,"title":["【配合剤の現状と展望】 配合剤でより早い血圧、血糖、脂質目標達成は可能か? アドヒアランスの問題も含めて"],"weko_creator_id":"3","weko_shared_id":-1},"updated":"2024-07-26T08:54:07.365987+00:00"}